New Study Reveals Value of ESR and CRP Lab Tests in Reducing Diagnostic Errors

Economic Study Supports ESR's Retention

A new economic analysis published in ClinicoEconomics and Outcomes Research sheds light on the value of the erythrocyte sedimentation rate (ESR) test in conjunction with the C-reactive protein (CRP) test. This study, sponsored by ALCOR Scientific, challenges the growing sentiment that ESR tests are redundant and can be eliminated to save costs.

Financial Implications of the Tests

The study highlights that hospitals could save nearly $9.95 million annually by employing a strategy that combines both ESR and CRP tests. The research points to a significant reduction in diagnostic errors when both tests are used together, emphasizing their complementary nature in diagnosing inflammatory conditions. The economic evaluation simulated outcomes based on a representative 739-bed academic medical center in the U.S., projecting substantial net savings from decreased downstream costs associated with erroneous diagnoses primarily caused by CRP's false positives.

Differences Between ESR and CRP

Critics of combined testing have often argued that ESR and CRP serve the same purpose and therefore are redundant. However, the study counters this notion by clarifying the fundamental differences in the behavior of these two tests. CRP levels rise quickly within hours following acute inflammation but normalize within days. In contrast, ESR levels rise slowly over 24 to 48 hours and remain elevated longer, making ESR particularly useful for identifying chronic and subacute inflammatory conditions such as polymyalgia rheumatica, giant cell arteritis, lupus, and certain malignancies.

The distinct biological kinetics suggest that both tests provide valuable clinical information when interpreted together, enhancing diagnostic accuracy compared to using either test in isolation.